| Alzheimer Disease |
1 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.99 |
| Schizophrenia |
0 |
0.72 |
| Psychosis |
0 |
0.98 |
| Dementia |
0 |
0.46 |
| Parkinson Disease |
0 |
0.27 |
| Diversity |
0 |
0.2 |
| Social Determinants of Health |
0 |
0.16 |
| Atypical Antipsychotics |
0 |
0.97 |
| Allergy |
0 |
0.07 |
| Antipsychotics |
0 |
0.07 |
| Arizona |
0 |
0.07 |
| Biostatistics |
0 |
0.07 |
| California |
0 |
0.07 |
| Caregiver |
0 |
0.07 |
| Drug and Treatment Safety |
0 |
0.07 |
| Drug Development |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Off-Label Use |
0 |
0.07 |
| Receptors |
0 |
0.07 |
| Depression |
0 |
0.05 |
| Patient Safety |
0 |
0.05 |